We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
Cap. Flow
-$1.7B
Cap. Flow %
-1.7%
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 16.9%
2 Industrials 13.89%
3 Financials 12.91%
4 Consumer Discretionary 10.69%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVEC icon
2601
NVE Corp
NVEC
$573M
$28K ﹤0.01%
523
-1,741
-77% -$103K
OTLK icon
2602
Outlook Therapeutics
OTLK
$215M
$28K ﹤0.01%
888
+3
+0.3% +$94
MBII
2603
DELISTED
Marrone Bio Innovations, Inc.
MBII
$28K ﹤0.01%
23,803
+867
+4% +$655
CEI
2604
DELISTED
Camber Energy, Inc
CEI
$28K ﹤0.01%
700
-20
-3% -$733
ANNX icon
2605
Annexon
ANNX
$883M
$27K ﹤0.01%
10,455
+66
+0.6% +$406
LCTX icon
2606
Lineage Cell Therapeutics
LCTX
$286M
$27K ﹤0.01%
22,410
-1,129
-5% -$1.75K
VRM icon
2607
Vroom Inc
VRM
$51.2M
$26K ﹤0.01%
206
+12
+6% +$5.69K
SPIR icon
2608
Spire Global
SPIR
$543M
$24K ﹤0.01%
1,780
-51
-3% -$996
NCMI icon
2609
National CineMedia
NCMI
$370M
$23K ﹤0.01%
1,060
-30
-3% -$835
NBIS
2610
Nebius Group N.V.
NBIS
$46.7B
$22K ﹤0.01%
45,921
+3,193
+7% +$152K
GORO icon
2611
Goldgroup Mining Inc.
GORO
$186M
$21K ﹤0.01%
11,739
+1,540
+15% +$2.85K
LXRX icon
2612
Lexicon Pharmaceuticals
LXRX
$1.07B
$21K ﹤0.01%
11,583
-16,368
-59% -$45.4K
OSG
2613
DELISTED
Overseas Shipholding Group Inc.
OSG
$21K ﹤0.01%
10,234
-292
-3% -$567
KOPN icon
2614
Kopin
KOPN
$780M
$20K ﹤0.01%
12,257
+723
+6% +$2.08K
MTNB icon
2615
Matinas BioPharma
MTNB
$1.72M
$20K ﹤0.01%
575
-16
-3% -$589
BIOR
2616
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$20K ﹤0.01%
96
+9
+10% +$3.42K
PGEN icon
2617
Precigen
PGEN
$2.51B
$19K ﹤0.01%
14,620
-418
-3% -$1.02K
TALK icon
2618
Talkspace
TALK
$878M
$19K ﹤0.01%
14,374
-250
-2% -$390
IMDX
2619
Insight Molecular Diagnostics
IMDX
$154M
$18K ﹤0.01%
770
+139
+22% +$4.44K
POL
2620
DELISTED
Polished.com Inc.
POL
$18K ﹤0.01%
286
-8
-3% -$786
XELA
2621
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$18K ﹤0.01%
14
+9
+180% +$22.6K
ATOS icon
2622
Atossa Therapeutics
ATOS
$23.6M
$16K ﹤0.01%
1,051
-103
-9% -$2.09K
CNVS icon
2623
Cineverse
CNVS
$66M
$16K ﹤0.01%
1,175
+5
+0.4% +$84
GPUS
2624
Hyperscale Data Inc
GPUS
$55.4M
0
SPPI
2625
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$15K ﹤0.01%
18,468
-1,567
-8% -$1.44K

Similar funds

Victory Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
  • Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
  • Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
  • Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
  • Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
  • Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
  • Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.